Millions of healthcare and essential workers have worn N95 respirators or other medical masks to protect themselves over the course of the COVID-19 pandemic. Current Centers for Disease Control and Prevention numbers indicate that over 148 million vaccines have been administered, the majority of which are Moderna or Pfizer doses. After a year of uncertainty,… Read More
A Mission for Making Good Medicine The University of Tennessee Research Foundation (UTRF), the University of Tennessee Health Science Center (UTHSC), and biotech therapeutics startup Anviron recently announced a partnership to commercialize a novel treatment with promising efficacy against pancreatic cancer tumors. According to the Genetic and Rare Diseases Information Center, the total number of… Read More
UTRF licensee Veru, Inc. announced today significant potential of VERU-111 in treating COVID-19, both as a broad-spectrum antiviral and an anti-inflammatory agent, which may help prevent effects leading to Acute Respiratory Distress Syndrome. Statistically significant data from the Phase 2 clinical study results show an 81% relative reduction in death or respiratory failure at Day… Read More
